As per our analysis, the Genomics Market size in the Asia Pacific was worth USD 3.62 billion in 2021 and estimated to be growing at a CAGR of 10.5%, to reach USD 5.97 billion by 2026.
Within molecular biology, genomics is the study of genomes, the complete set of genetic material within an organism. Genomics involves the sequencing and analysis of genomes. Genomics is also concerned with the structure, function, comparison, and evolution of genomes.
The Asia Pacific genomics market is expected to grow at the highest CAGR during the forecast period due to increasing awareness and adoption of various genomics techniques in emerging countries such as India and China for detection, prognosis, and treating various genetic disorders like cancer, diabetes, and others. In addition to this, improving healthcare infrastructure, high unmet medical needs, rising patient disposable incomes, and growing health care expenditures are also the drivers for the growth of this market.
However, the expensive genomic instruments pose a major problem to the growth of the APAC genomics market.
This research report on the APAC Genomics Market has been segmented & sub-segmented into the following categories:
By Product:
By Technology:
By Process:
By Application:
By End User:
By Country:
Geographically, the Asia Pacifica genomics market is one of the fastest-growing regional markets in the global market. The market is anticipated to witness a significant share in the Genomics market during the forecast period. The market is growing is attributed to the improving healthcare infrastructure, supportive government initiatives, and investments. The Asia Pacific market would benefit from human genetic research in public health programs such as consumer health programs and population screening to maximize the preventative treatment of prevalent chronic diseases. Also, developing countries such as China, India, and Japan are rapidly contributing to the APAC regional market growth.
The Chinese genomics market is expected to lead the APAC market during the forecast period and will account significant share during the forecast period. However, the market is expected to witness the largest share during the forecast period. The increasing advances in genetic and genomic technology have changed healthcare services. Therefore, the country is focusing on prevention through carrier screening, genetic counseling, and prenatal diagnosis.
On the other hand, the Indian genomics market is anticipated to witness a promising market share and contribute to the APAC regional market growth. Increasing research and development activities and favorable reimbursement policies are fuelling the market growth. Indian scientists have begun genome sequencing of coronavirus strains as part of a major sequencing effort coordinated by the National Centre for Disease Control in New Delhi. Moreover, the Indian government is assisting Haystack Analytics in utilizing genome sequencing methods to study viral transmission. The increasing number of startups and similar efforts is expected to boost the market growth in the future years.
Similarly, the Japanese genomics market is projected to showcase a promising share in the APAC market. The market players are implementing various strategies such as partnerships, collaborations, and mergers to gain a competitive advantage. For instance, the National Cancer Center of Japan (NCC) and Chugai Pharmaceutical, Ltd. partnered in February 2020 to utilize FoundationOneLiquid in the third stage of Japan's cancer genomic screening collaboration. The genetic testing services market in Japan grew as a result of this.
KEY MARKET PLAYERS:
Companies playing a significant role in the APAC genomics market profiled in this report are Affymetrix, Inc., Agilent Technologies, BGI, Bio-Rad Laboratories Inc., GE Healthcare, Illumina Inc., Qiagen, Roche Diagnostics, Life Technologies, and Cepheid.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Instruments/systems
5.1.3 Consumables
5.1.4 Services
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2 Process
5.2.1 Introduction
5.2.2 Library prepration
5.2.3 Sequencing and imaging
5.2.4 Data Analysis
5.2.5 Y-o-Y Growth Analysis, By Process
5.2.6 Market Attractiveness Analysis, By Process
5.2.7 Market Share Analysis, By Process
5.3 Technology
5.3.1 Introduction
5.3.2 Sequencing
5.3.3 Microarray technology
5.3.4 PCR
5.3.5 Nucleic Acid Extraction and Purification
5.3.6 Other technologies
5.3.7 Y-o-Y Growth Analysis, By Technology
5.3.8 Market Attractiveness Analysis, By Technology
5.3.9 Market Share Analysis, By Technology
5.4 Application
5.4.1 Introduction
5.4.2 Diagnostics
5.4.2.1 Cancer diagnostics
5.4.2.2 Monogenic diagnostics
5.4.2.3 Other diagnostic applications
5.4.3 Drug discovery and development
5.4.4 Personalized medicine
5.4.5 Agriculture and animal research
5.4.6 Other applications
5.4.7 Y-o-Y Growth Analysis, By Application
5.4.8 Market Attractiveness Analysis, By Application
5.4.9 Market Share Analysis, By Application
5.5 End user
5.5.1 Introduction
5.5.2 Research Centers, Academic Institutes, and Government Institutes
5.5.3 Hospitals and clinics
5.5.4 Pharmaceutical and biotechnological companies
5.5.5 Other end users
5.4.6 Y-o-Y Growth Analysis, By End user
5.4.7 Market Attractiveness Analysis, By End user
5.4.8 Market Share Analysis, By End user
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Process
6.1.3.4 By Technology
6.1.3.5 By Application
6.1.3.6 By end user
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Process
6.1.4.4 By Technology
6.1.4.5 By Application
6.1.4.6 By end user
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Process
6.1.5.4 By Technology
6.1.5.5 By End user
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Affymetrix Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Agilent Technologies
8.3 BGI
8.4 Bio-Rad Laboratories Inc.
8.5 GE Healthcare
8.6 Illumnia Inc.
8.7 Qiagen
8.8 Roche Diagnostics
8.9 Life technologies
8.10 Cepheid
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Apr 2021
